CATEGORY HUB
Eye
Eye verdicts ranked by evidence score. 19 verdicts in this category.
Eye Evidence Ranking
Within this category, verdicts with higher evidence scores appear first. Verdicts without a score stay lower in the same list.
-
B
60
Vitamin A (retinol/beta-carotene)
x Eye health, night blindness, skin, and immunity
Evidence for correcting deficiency and for night blindness and xerophthalmia corresponds to B, but claims of general eye, skin, and immune improvem... · View verdict → -
B
60
Maqui berry extract (Aristotelia chilensis)
x Improvement in dry eye and tear production
Tear volume and patient symptoms were replicated across two placebo-controlled RCTs, but supplied-ingredient concentration and small samples result... · View verdict → -
C
59
Palmitoylethanolamide (PEA)
x Adjunctive support for intraocular pressure and glaucoma
The intraocular-pressure surrogate is repeatedly positive, but total samples are small and clinical glaucoma-progression outcomes remain uncertain,... · View verdict → -
C
58
Tisochrysis lutea powder
x Improvement of dry-eye symptoms and tear secretion
The primary OSDI endpoint was positive, but objective measures were partial and no independent replication exists, resulting in C with 58 points. · View verdict → -
C
57
Grape-skin enzymatic fermented extract (KL-GEFE)
x Improvement of dry eye and tear-film measures
One RCT found concurrent improvement in symptoms and tear-film measures, but it was a single developer-linked study, resulting in C with 57 points. · View verdict → -
C
56
Centella asiatica extract powder
x Maintenance of macular pigment density and eye health
One randomized trial supports improved MPOD, but there are no visual-function or macular-degeneration prevention outcomes and no independent replic... · View verdict → -
C
55
Astaxanthin (astaxanthin, Haematococcus extract)
x eye fatigue, skin health, and antioxidant effects
Human RCTs and a skin meta-analysis exist, but most are small, short-term, industry-funded, and centered on surrogate markers, so C is the limit fo... · View verdict → -
C
49
Persimmon-leaf ethanolic extract
x Improvement of dry eye
Several dry-eye measures were positive, but the evidence is one company-funded preprint centered on completer analysis, resulting in C with 54 points. · View verdict → -
C
47
Purple corn cob and husk extract powder
x Improvement of dry eyes
A human trial was conducted, but no public literature permits independent verification of its results, resulting in C with 47 points. · View verdict → -
C
46
Bilberry extract (anthocyanins/anthocyanosides)
x eye fatigue, eye health, vision/night vision, and dry-eye-related claims
Eye fatigue has surrogate-marker signals from industry-funded small RCTs, but improvement of vision and night vision is not supported by more direc... · View verdict → -
C
45
Perilla leaf extract
x Eye-fatigue relief
Small brief studies found an accommodation signal, but independent replication and clinical symptom data are insufficient, resulting in C with 45 p... · View verdict → -
C
44
Sea buckthorn oil (Hippophae rhamnoides)
x Dry-eye symptoms and tear-film improvement
A single manufacturer-linked RCT showed limited signals in selected endpoints alongside many null endpoints, resulting in C with 44 points. · View verdict → -
C
43
Goji berry (wolfberry, Lycium barbarum/goji berry)
x Eye, fatigue, immunity, antioxidant
Eye and antioxidant signals are mostly surrogate markers, and direct clinical evidence for fatigue and immunity is weak, so this is C. · View verdict → -
C
43
Gardenia-derived crocetin
x Improvement of eye fatigue and accommodation
Only one positive small manufacturer-linked crossover trial is available, resulting in C with 43 points. · View verdict → -
C
42
Dried Tetraselmis chuii powder
x Improvement of dry eye and tear secretion
A human study exists in the regulatory dossier, but its results cannot be independently checked in public, resulting in C with 42 points. · View verdict → -
D
32
Omega-3 (EPA/DHA)
x Dry eye disease
Because the primary endpoint in an independent large RCT was null, this is D. · View verdict → -
C
score not listed
Lutein and zeaxanthin
x macular health and eye health
The evidence is conflicting or limited. · View verdict → -
?
score not listed
Chrysanthemum flower (Chrysanthemum indicum)
x Eye-fatigue relief and vision protection
Kan 2020 tested a C. morifolium combination, and no oral monotherapy RCT exists for C. indicum, so the grade is ?. · View verdict → -
?
score not listed
Eyebright (Euphrasia officinalis)
x Eye-fatigue relief and vision protection
Eye-drop studies exist, but there is no efficacy literature for oral eyebright on the target outcomes, so the grade is ?. · View verdict →